Scientific publications

Scientific Publication
21.09.2020

TOTUM-63 REDUCES BODY WEIGHT AND IMPROVES INSULIN SENSITIVITY IN OBESE MICE THROUGH PLEIOTROPIC EFFECTS ON VARIOUS METABOLIC ORGANS

View
Scientific Publication
21.09.2020

TOTUM-63 LOWERS FASTING GLYCEMIA IN SUBJECTS WITH PREDIABETES: A PHASE II CLINICAL TRIAL

View
Scientific Publication
21.09.2020

TOTUM-63: A NEW PROMISING APPROACH FOR THE MANAGEMENT OF OBESITY AND RISK REDUCTION FOR DEVELOPING TYPE 2 DIABETES

View
Scientific Publication
21.09.2020

TOTUM-63: A NEW PROMISING APPROACH FOR THE MANAGEMENT OF OBESITY AND RISK REDUCTION FOR DEVELOPING TYPE 2 DIABETES

View
Scientific Publication
12.06.2020

American Diabetes Association 2020 – 80th scientific sessions -TOTUM-63 lowers fasting glycemia in subjects with prediabetes: a phase II clinical trial

View
Scientific Publication
16.09.2019

European Association for the Study of Diabetes (EASD) annual congress 2019 – TOTUM-63 corrects levels of hormones associated to type 2 diabetes.

View
Scientific Publication
07.06.2019

American Diabetes Association 2019 – 79th scientific sessions – TOTUM-63 lowers adipose tissue inflammation

View
Scientific Publication
12.11.2018

American Association for the Study of Liver Diseases (AASLD), 2018 Congress – TOTUM-63 reduces hepatic steatosis

View
Scientific Publication
04.10.2018

European Association for the Study of Diabetes (EASD), 2018 Congress, Berlin (Germany) – TOTUM-63 multi-target mode of action

View